FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2015/10/006296 [Registered on: 23/10/2015] Trial Registered Retrospectively
Last Modified On: 04/12/2018
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Single Arm Study 
Public Title of Study   To study the medicinal effectiveness of Unani formulation “Sharbat Toot Siyah” in cases of Waram-i-Halaq (Pharyngitis) 
Scientific Title of Study   Clinical Validation of Unani Pharmacopoeial formulation “Sharbat Toot Siyah” in cases of Waram-i-Halaq (Pharyngitis) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
WH/STS/CLN VAL/CCRUM 14-15 Version No: 01  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  PROF RAIS UR RAHMAN 
Designation  DIRECTOR GENERAL 
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

West
DELHI
110058
India 
Phone  9313980776  
Fax  01128522965  
Email  drrahman002@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR KHALID M SIDDIQUI 
Designation  DEPUTY DIRECTOR GENERAL 
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

West
DELHI
110058
India 
Phone  9810161758  
Fax  01128522965  
Email  ccrum507@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR PRADEEP KUMAR 
Designation  RESEARCH OFFICER SCIENTIST III  
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

West
DELHI
110058
India 
Phone  8800263300  
Fax  01128522965  
Email  drpradeepkumar2001@gmail.com  
 
Source of Monetary or Material Support  
InfrastructuralSupport:1.Regional Research Institute of Unani Medicine, Bhadrak 2.Regional Research Institute of Unani Medicine Patna, 3. Regional Research Institute of Unani Medicine Mumbai 4.Regional Research Institute of Unani Medicine Chennai 5. Regional Research Centre (RRC), Silchar 6. Clinical Research Unit Kurnool Monetary Support : Central Council for Research in Unani Medicine, New Delhi 
 
Primary Sponsor  
Name  Central Council for Research in Unani Medicine 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi-110058.  
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 4  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shoab Ahmad Khan  Regional Research Institute of Unani Medicine (RRIUM), Bhadrak  Chand bali By pass Road
Bhadrak
ORISSA 
07205584347

drshoaibkhanbumsk@gmail.com 
Hkm N Zaheer Ahmad  Regional Research Institute of Unani Medicine (RRIUM), Chennai  No.1, West Madha Church Road, Royapuram
Chennai
TAMIL NADU 
9884764658

drnzaheer@gmail.com 
Dr Irfan Ahmad  Regional Research Institute of Unani Medicine (RRIUM), Mumbai  Sir J J Hospital Compound
Mumbai
MAHARASHTRA 
09987427379

Irfanmumbai8@gmail.com 
Dr Mrs Najmus Sehar  Regional Research Institute of Unani Medicine (RRIUM), Patna  Guzri, Patna City
Patna
BIHAR 
09431651861

nsehar.ccrum@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 4  
Name of Committee  Approval Status 
Regional Research Institute of Unani Medicine (RRIUM), Bhadrak  Approved 
Regional Research Institute of Unani Medicine (RRIUM), Chennai  Approved 
Regional Research Institute of Unani Medicine (RRIUM), Mumbai  Approved 
Regional Research Institute of Unani Medicine (RRIUM), Patna  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J029||Acute pharyngitis, unspecified, Waram-i-Halaq (Pharyngitis),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NA 
Intervention  Sharbat Toot Siyah  20 ml orally twice daily for one week  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients of either sex in the age group of 18-60 years.
2. Presence of all of the following signs and symptoms of Waram-i-Halaq (Pharyngitis):
1. Buhha al-Sawt (Hoarseness of Voice)
2. Surfa Yubsiyya (Dry Cough)
3. ‘Usr al-Bal (Dysphagia)
4. Humāma Bul’ūm (Pharyngeal Erythema
5. Waja–e-halaq (Pain in throat).
6. Khushuna al-Halaq (Irritation in throat).
 
 
ExclusionCriteria 
Details  1. Patients with all four classic symptoms of Group A Streptococcal pharyngitis:
• Pharyngeal or Tonsillar exudates
• Swollen anterior cervical nodes
• History of fever more than 380 C
• Absence of cough
2. Known cases of Renal/ Hepatic/ Cardiac ailments/ Diabetes mellitus
3. Pregnant and lactating women
4. Oral candidiasis
5. Epiglottitis,
6. Herpes Simplex
7. Mononucleosis
8. Gastro esophageal reflux
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in signs and symptoms of Waram-i-Halaq (Pharyngitis)  1 WEEK 
 
Secondary Outcome  
Outcome  TimePoints 
Haematological and biochemical assessment for safety assessment   1 WEEK 
 
Target Sample Size   Total Sample Size="246"
Sample Size from India="246" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   02/04/2015 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
This study is designed as a multicentric open trial in patients with Waram-i-Halaq (Pharyngitis)  After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically on Baseline, 3rd and 7th day of treatment.  This includes subjective assessment of general well being and physical examination . The total duration of treatment will be one week. . Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy. 

Composition of Sharbat Toot Siyah

S. No.

Unani Name

Scientific Name

Weight

1.

Aab-e-Toot Siyah

Morusnigra Linn.

1litre

2.

Qand Safaid

Honey or sugar

1.5kg

 
Close